e-learning
resources
London 2016
Sunday, 04.09.2016
Pulmonary drug delivery
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Stimulation with polyinosinic-polycytidylic acid (poly(I:C)) encapsulated within novel pH-sensitive switchable liposomes leads to a faster and more potent interferon response
Larry Lands (Montreal, Canada), Nurlan Dauletbaev, Maria Cammisano, Warren Viricel, Suli-Anne Laurin, Jeanne Leblond-Chain, Larry Lands
Source:
International Congress 2016 – Pulmonary drug delivery
Session:
Pulmonary drug delivery
Session type:
Thematic Poster
Number:
965
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Larry Lands (Montreal, Canada), Nurlan Dauletbaev, Maria Cammisano, Warren Viricel, Suli-Anne Laurin, Jeanne Leblond-Chain, Larry Lands. Stimulation with polyinosinic-polycytidylic acid (poly(I:C)) encapsulated within novel pH-sensitive switchable liposomes leads to a faster and more potent interferon response. Eur Respir J 2016; 48: Suppl. 60, 965
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Cytoplasmic signaling of polyinosinic-polycytidylic acid stimulates a quick and potent interferon response in primary macrophages
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
Cytotoxicity of liposome-encapsulated polyinosinic-polycytidylic acid in primary human macrophages is only partially related to interferon-ß
Source: International Congress 2018 – Basic pharmacology
Year: 2018
Increased expression of microRNA-146a negatively regulates both the LPS and Poly (I:C) induced inflammatory response in monocytes
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Synthetic response of stimulated respiratory epithelium: Modulation by prednisolone and iKK2 inhibition
Source: Annual Congress 2012 - New insights into airway epithelial cell physiology
Year: 2012
Drug loaded liposomes of mesalamine incorporated into disease responsive microgels (Micro) for treating allergic asthma: An approach using smart drug delivery system
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
The oppositedirection of LC3 A/B-I/II change in Raw264.7 cells and A549 cells treated with graphene oxide and its functionalized chemicals
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Temporal characterization of murine genomic response to poly I:C stimulation reveals tri-phasic inflammatory response signatures
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
Fast, efficient and realistic
in vitro
delivery of inhaled drugs to pulmonary cells: Application to the proteasome inhibitor bortezomib
Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways
Year: 2013
Designed core-shell nanoparticles: intracellular localization and pro-inflammatory cytokine release in lung cells
Source: Annual Congress 2009 - Lung cell biology and immunology
Year: 2009
A molecule derived from mycobacterium tuberculosis
Cpn60.1 (compound Y) inhibits lung inflammation induced by LPS in mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Inhibition of the effect of epidermal growth factor (EGF) on lung cancer cells. The use of plasmids encoding specific siRNA molecules
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Double-stranded RNA analog, poly I:C modulates histamine-triggered Ca
2+
signaling in human pulmonary arterial endothelial cells
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
Late Breaking Abstract: Suppressed rhinovirus (RV) induced type III interferon production in alternatively activated macrophages
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
TNF alpha promotes coxsackie and adenovirus receptor (CAR) phosphorylation by PKC delta to drive leukocyte transepithelial migration
Source: International Congress 2014 – Cell biology 2014
Year: 2014
The antifibrotic effect of Imatinib loaded CD44 targeted gold nanoparticles (Im-CD44-GNP) relies on alveolar macrophage regulation
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Pirfenidone induced inhibition of p38 downregulates procoagulant microparticle generation by human alveolar epithelia cells
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Stimulation of IL-8 release in respiratory cell cultures by increasing IL1-beta concentrations: Effect of budesonide
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Effects of functionalised chalcones on pro-inflammatory mediator release from lung epithelial cells
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009
Recombinant human pulmonary surfactant protein-D (rhSP-D) modulates Th2 responses and suppresses IgE-facilitated allergen binding to B cells
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
The relationship between PBMC secretion of IFN-alpha following stimulation by Poly (I:C) and clinical indices in COPD
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept